Evidence map›Paper›PMID 33302440›Full record

ArticleInternational journal of molecular sciences2020

Anti-Stem Cell Property of Pterostilbene in Gastrointestinal Cancer Cells.

Shiori Mori, Shingo Kishi, Kanya Honoki, Rina Fujiwara-Tani, Takuma Moriguchi, Takamitsu Sasaki, Kiyomu Fujii, Shinji Tsukamoto, Hiromasa Fujii, Akira Kido and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Attacking Cancer Progression and Metastasis.International journal of molecular sciences · 2023
    Article
  9. Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines.International journal of molecular sciences · 2023
    Article
  10. Article
  11. An Axis between the Long Non-Coding RNAInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.International journal of molecular sciences · 2021
    Article
  18. Pterostilbene in Cancer Therapy.Antioxidants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Shiori MoriDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Shingo KishiDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Kanya HonokiDepartment of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Rina Fujiwara-TaniDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Takuma MoriguchiDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Takamitsu SasakiDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Kiyomu FujiiDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Shinji TsukamotoDepartment of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.ORCID 0000-0002-8419-2008
Hiromasa FujiiDepartment of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Akira KidoDepartment of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Yasuhito TanakaDepartment of Orthopedics, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.ORCID 0000-0002-2300-611X
Yi LuoDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Hiroki KuniyasuDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.ORCID 0000-0003-2298-8825
Nara Medical University · JPNantong University · CN

Funding

Ministry of Education, Culture, Sports, Science and Technology 19K16564Ministry of Education, Culture, Sports, Science and Technology 20K19349Ministry of Education, Culture, Sports, Science and Technology 20K21659National Natural Science Foundation of China 81702723Natural Science Foundation of Jiangsu Education Department Project 17KJB320010
6 · The paper itself

Abstract

Pterostilbene (PTE) is a natural sterbenoid contained in blueberries that has an antioxidant effect. In contrast, PTE also generates oxidative stress in cancer cells and provides an antitumor effect. Here, we examined the potential mechanism of this contrasting effect of PTE using three gastrointestinal cancer cell lines, namely CT26, HT29, and MKN74. PTE showed a dose-dependent inhibition of cell proliferation, sphere-forming ability, and stem cell marker expression in all three cell lines. Furthermore, the cells treated with PTE showed an increase in mitochondrial membrane potential and an increase in mitochondrial oxidative stress and lipid peroxide. Upon concurrent treatment with vitamin E, N-acetyl-L-cysteine, and PTE, the PTE-induced mitochondrial oxidative stress and growth inhibition were suppressed. These findings indicate that PTE induces oxidative stress in cancer cells, suppresses stemness, and inhibits proliferation. These antitumor effects of PTE are considered to be useful in cancer treatment.

Indexed as

AcetylcysteineAnimalsAntineoplastic AgentsCell ProliferationGastrointestinal NeoplasmsHT29 CellsHumansLipid PeroxidationMiceNeoplastic Stem CellsStilbenesVitamin EAcetylcysteineAntineoplastic AgentspterostilbeneStilbenesVitamin Ecanceroxidative stresspterostilbenestemness

Identifiers

PMID33302440
PMCPMC7762551
OpenAlexW3112089811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.